ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Endocrine Testing in Transgender Individuals
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 229164" data-attributes="member: 13851"><p>[URL unfurl="true"]https://arup.utah.edu/education/straseski-inclusivity-2022.php[/URL]</p><p></p><p></p><p><em><strong>Choosing the right laboratory test for any clinical situation can be difficult. One particularly complex situation is choosing appropriate testing for transgender and nonbinary patients. Gender and sex are words that many use interchangeably, however, understanding their differences is key to creating systems that accurately represent transgender patients. Correct identification and representation of all people and clinical scenarios allow laboratories to provide accurate results for the right test.</strong></em></p><p><em><strong></strong></em></p><p><em><strong></strong></em></p><p><em><strong></strong></em></p><p><em><strong></strong></em></p><p><em><strong>Dr. Straseski is a professor (clinical) at the University of Utah School of Medicine. She received her Ph.D. in pathology and laboratory medicine and a master of science in bacteriology from the University of Wisconsin-Madison, where she also served as a postdoctoral associate in the Department of Pathology. Dr. Straseski completed a postdoctoral fellowship in clinical chemistry at the Johns Hopkins Medical Institutions in Baltimore, Maryland. She is an active member of the American Association for Clinical Chemistry and American Society for Clinical Pathology, a fellow of the AACC Academy, and the chair of the board of editors for Clinical Laboratory News. Dr. Straseski is board certified in clinical chemistry by the American Board of Clinical Chemistry.</strong></em></p><p></p><p></p><p></p><p></p><p><strong>Objectives</strong></p><p><strong></strong></p><p><strong>After this presentation, participants will be able to:</strong></p><p></p><ul> <li data-xf-list-type="ul"><strong><em><em><strong>Define terms associated with the gender identity of transgender and nonbinary individuals, including sex, gender, the prefixes cis- and trans-, gender incongruence, and gender dysphoria</strong></em></em></strong></li> <li data-xf-list-type="ul"><strong><em><strong><em>Identify the utility and mechanism of gender-affirming hormone therapies in transgender and nonbinary individuals</em></strong></em></strong></li> <li data-xf-list-type="ul"><strong><em><strong><em>Evaluate the utility of immunoassay and mass spectrometry methods for both testosterone and estrogen measurements</em></strong></em></strong></li> <li data-xf-list-type="ul"><strong><em><em><strong>Describe possible solutions to laboratory-specific challenges faced by transgender individuals</strong></em></em></strong></li> </ul></blockquote><p></p>
[QUOTE="madman, post: 229164, member: 13851"] [URL unfurl="true"]https://arup.utah.edu/education/straseski-inclusivity-2022.php[/URL] [I][B]Choosing the right laboratory test for any clinical situation can be difficult. One particularly complex situation is choosing appropriate testing for transgender and nonbinary patients. Gender and sex are words that many use interchangeably, however, understanding their differences is key to creating systems that accurately represent transgender patients. Correct identification and representation of all people and clinical scenarios allow laboratories to provide accurate results for the right test. Dr. Straseski is a professor (clinical) at the University of Utah School of Medicine. She received her Ph.D. in pathology and laboratory medicine and a master of science in bacteriology from the University of Wisconsin-Madison, where she also served as a postdoctoral associate in the Department of Pathology. Dr. Straseski completed a postdoctoral fellowship in clinical chemistry at the Johns Hopkins Medical Institutions in Baltimore, Maryland. She is an active member of the American Association for Clinical Chemistry and American Society for Clinical Pathology, a fellow of the AACC Academy, and the chair of the board of editors for Clinical Laboratory News. Dr. Straseski is board certified in clinical chemistry by the American Board of Clinical Chemistry.[/B][/I] [B]Objectives After this presentation, participants will be able to:[/B] [LIST] [*][B][I][I][B]Define terms associated with the gender identity of transgender and nonbinary individuals, including sex, gender, the prefixes cis- and trans-, gender incongruence, and gender dysphoria[/B][/I][/I][/B] [*][B][I][B][I]Identify the utility and mechanism of gender-affirming hormone therapies in transgender and nonbinary individuals[/I][/B][/I][/B] [*][B][I][B][I]Evaluate the utility of immunoassay and mass spectrometry methods for both testosterone and estrogen measurements[/I][/B][/I][/B] [*][B][I][I][B]Describe possible solutions to laboratory-specific challenges faced by transgender individuals[/B][/I][/I][/B] [/LIST] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Endocrine Testing in Transgender Individuals
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top